DIABÉTIX is a flagship company of Franco Indian Pharmaceuticals Private Limited, founded in the year 2006 by Mr. M. Postel, with an objective to produce drugs to treat Diabetes and Heart diseases. Under the able guidance and vision of the Founder, DIABÉTIX has emerged as one of the most sought after companies for its qualitative drugs and formulations, notably for Type 2 Diabetes, Cardiovascular, Anti - Obesity & Neuropathy. A Dedicated Marketing, Production and R&D team numbering more than 500, support the company's vision and progress.

DIABÉTIX has emerged as a leader in the oral
anti-diabetic segment, thanks to the stringent and high quality standards maintained by the production process and continuous research carried out by R&D. Overwhelming Support, Trust and Recognition extended by the medical fraternity is a testimony to its efforts. With continued support, DIABÉTIX is all set to reach various sections of the people in India and across the Globe.